Skip to main content
Livermore
Livermore
ZHEN

Ascendis Pharma A/S

ASND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001612042

In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Ascendis Pharma A/S changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of ASND: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders1872164−21
Shares65.9M158.8K61.0M−4.76M (−7.2%)
Value$8.05B$19.0M$6.54B−$1.50B (−18.6%)

2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (16)

Institutions that held Ascendis Pharma A/S at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to ASND in Q1 2023
InstitutionSharesValue% of portfolio
PFM Health Sciences, LP202,115$21.7M1.00%
Logos Global Management LP150,000$16.1M2.30%
Alyeska Investment Group, L.P.45,000$4.82M0.04%
Berylson Capital Partners, LLC13,600$1.46M3.67%
CM Wealth Advisors LLC17,254$1.32M0.26%
Allianz Asset Management GmbH11,200$1.20M0.00%
Gratus Capital LLC5,000$536.1K0.04%
Fox Run Management, L.L.C.4,427$474.7K0.15%
Algert Global LLC2,779$298.0K0.01%
HRT Financial LP2,524$270.0K0.00%
Aquatic Capital Management LLC2,500$268.0K0.02%
Two Sigma Securities, LLC2,240$240.2K0.02%
Clearstead Advisors, LLC620$66.5K0.00%
Bessemer Group Inc544$58.0K0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)205$22.0K0.00%
Bogart Wealth, LLC34$3.65K0.00%

Sold out (37)

Institutions that held Ascendis Pharma A/S at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of ASND in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Baker Bros. Advisors LP4,954,855$605.1M
Deep Track Capital, LP700,000$85.5M
Tri Locum Partners LP99,215$12.1M
Sessa Capital IM, L.P.58,500$7.14M
Cormorant Asset Management, LP50,000$6.11M
Tang Capital Management LLC36,090$4.41M
Arrowstreet Capital, Limited Partnership29,218$3.57M
Tudor Investment Corp Et Al27,476$3.36M
Silverarc Capital Management, LLC23,151$2.83M
Moore Capital Management, LP20,000$2.44M
Capital Fund Management S.A.16,351$2.00M
Fred Alger Management, LLC14,556$1.78M
Cubist Systematic Strategies, LLC9,603$1.17M
Millennium Management LLC7,524$919.0K
Susquehanna International Group, LLP7,081$864.8K
Bayesian Capital Management, LP6,500$793.8K
Engineers Gate Manager LP5,368$655.6K
First Trust Advisors LP3,602$439.9K
Industrial Alliance Investment Management Inc.3,428$419.0K
Legato Capital Management LLC2,701$329.9K
DuPont Capital Management Corp2,324$283.8K
Pathstone Family Office, LLC2,242$261.7K
HC Advisors, LLC2,075$253.4K
Trexquant Investment LP2,050$250.4K
SG3 Management, LLC2,000$244.3K
Y-Intercept (Hong Kong) Ltd1,764$215.4K
LPL Financial LLC1,736$212.0K
Simplex Trading, LLC1,617$197.0K
Group One Trading, L.P.1,235$150.8K
TCI Wealth Advisors, Inc.67$8.18K
Zions Bancorporation, N.A.39$4.76K
McElhenny Sheffield Capital Management, LLC13$1.59K
Rockefeller Capital Management L.P.24$1.00K
Ronald Blue Trust, Inc.6$1.00K
Money Concepts Capital Corp1$122
Coppell Advisory Solutions LLC50$90
Coppell Advisory Solutions Corp.50$90

Not filed for Q1 2023 yet (2)

Institutions that held Ascendis Pharma A/S at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ASND in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Comerica Bank153,719$18.4M
Zeke Capital Advisors, LLC5,113$624.5K